These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 26228038)

  • 21. Combined high-fat diet and sustained high sucrose consumption promotes NAFLD in a murine model.
    Torres-Villalobos G; Hamdan-Pérez N; Tovar AR; Ordaz-Nava G; Martínez-Benítez B; Torre-Villalvazo I; Morán-Ramos S; Díaz-Villaseñor A; Noriega LG; Hiriart M; Medina-Santillán R; Castillo-Hernandez Mdel C; Méndez-Sánchez N; Uribe M; Torres N
    Ann Hepatol; 2015; 14(4):540-6. PubMed ID: 26019041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
    Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.
    He Q; Li JK; Li F; Li RG; Zhan GQ; Li G; Du WX; Tan HB
    World J Gastroenterol; 2015 Feb; 21(7):2058-66. PubMed ID: 25717238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary sucrose regulates the expression of the Cd36 gene in hepatic tissue of rats with obesity and Non Alcoholic Fatty Liver Disease (NAFLD).
    Castro RQ; Soto Rodriguez I; Deschamps Lago RA; Pagola PG; Rodriguez Antolin J; Peres Quintal A; Rivera JR; Aguilera AA
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Jun; 162(2):99-106. PubMed ID: 29765172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers.
    Al-Muzafar HM; Amin KA
    BMC Complement Altern Med; 2017 Jan; 17(1):43. PubMed ID: 28086768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does propolis have any effect on non-alcoholic fatty liver disease?
    Kismet K; Ozcan C; Kuru S; Gencay Celemli O; Celepli P; Senes M; Guclu T; Sorkun K; Hucumenoglu S; Besler T
    Biomed Pharmacother; 2017 Jun; 90():863-871. PubMed ID: 28437890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-γ and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet.
    Zheng F; Cai Y
    Lipids Health Dis; 2019 Jan; 18(1):6. PubMed ID: 30611282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
    Zhou C; Zhou J; Han N; Liu Z; Xiao B; Yin J
    Int Immunopharmacol; 2015 Mar; 25(1):218-28. PubMed ID: 25661699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect?
    Safwat GM; Pisanò S; D'Amore E; Borioni G; Napolitano M; Kamal AA; Ballanti P; Botham KM; Bravo E
    Nutrition; 2009; 25(11-12):1157-68. PubMed ID: 19592219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
    Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
    Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model.
    Braud L; Battault S; Meyer G; Nascimento A; Gaillard S; de Sousa G; Rahmani R; Riva C; Armand M; Maixent JM; Reboul C
    J Nutr Biochem; 2017 Feb; 40():95-104. PubMed ID: 27866076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet.
    Xia SF; Le GW; Wang P; Qiu YY; Jiang YY; Tang X
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease.
    Korish AA; Arafah MM
    BMC Complement Altern Med; 2013 Oct; 13():264. PubMed ID: 24119413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
    Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
    J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein.
    Yamazaki T; Kishimoto K; Miura S; Ezaki O
    J Nutr Biochem; 2012 Feb; 23(2):123-32. PubMed ID: 21447441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
    Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
    Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.